Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan.

Gonzalez A, Rota M, Nurzynska D, Misao Y, Tillmanns J, Ojaimi C, Padin-Iruegas ME, Müller P, Esposito G, Bearzi C, Vitale S, Dawn B, Sanganalmath SK, Baker M, Hintze TH, Bolli R, Urbanek K, Hosoda T, Anversa P, Kajstura J, Leri A.

Circ Res. 2008 Mar 14;102(5):597-606. doi: 10.1161/CIRCRESAHA.107.165464.

2.

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.

Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P, Leri A.

Circ Res. 2004 Mar 5;94(4):514-24.

3.

Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure.

Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A, Leri A, Maseri A, Anversa P.

Circ Res. 2003 Oct 3;93(7):604-13.

4.

Formation of large coronary arteries by cardiac progenitor cells.

Tillmanns J, Rota M, Hosoda T, Misao Y, Esposito G, Gonzalez A, Vitale S, Parolin C, Yasuzawa-Amano S, Muraski J, De Angelis A, Lecapitaine N, Siggins RW, Loredo M, Bearzi C, Bolli R, Urbanek K, Leri A, Kajstura J, Anversa P.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1668-73. doi: 10.1073/pnas.0706315105.

5.

Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function.

Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J, Fiumana E, Rastaldo R, Arcarese ML, Mitchell TS, Boni A, Bolli R, Urbanek K, Hosoda T, Anversa P, Leri A, Kajstura J.

Circ Res. 2008 Jul 3;103(1):107-16. doi: 10.1161/CIRCRESAHA.108.178525.

6.

Aging Effects on Cardiac Progenitor Cell Physiology.

Rota M, Goichberg P, Anversa P, Leri A.

Compr Physiol. 2015 Sep 20;5(4):1775-814. doi: 10.1002/cphy.c140082. Review.

PMID:
26426466
7.

Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival.

Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, Rotatori F, Rastaldo R, Musso E, Quaini F, Leri A, Kajstura J, Anversa P.

Circ Res. 2005 Sep 30;97(7):663-73. Erratum in: Circ Res. 2006 Feb 17;98(3):e27.

8.

Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene.

Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G, Vitale S, Urbanek K, Casarsa C, Giorgio M, Lüscher TF, Pelicci PG, Anversa P, Leri A, Kajstura J.

Circ Res. 2006 Jul 7;99(1):42-52.

9.

Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.

Nadal-Ginard B, Kajstura J, Leri A, Anversa P.

Circ Res. 2003 Feb 7;92(2):139-50. Review.

10.

Bone marrow-derived cells: the influence of aging and cellular senescence.

Beauséjour C.

Handb Exp Pharmacol. 2007;(180):67-88. Review.

PMID:
17554505
11.

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice.

Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, Tokunaga M, Shimizu T, Okano T, Kasanuki H, Hagiwara N, Komuro I.

J Clin Invest. 2009 Aug;119(8):2204-17. doi: 10.1172/JCI37456.

12.

Telomerase activity in rat cardiac myocytes is age and gender dependent.

Leri A, Malhotra A, Liew CC, Kajstura J, Anversa P.

J Mol Cell Cardiol. 2000 Mar;32(3):385-90.

PMID:
10731438
14.

c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy.

Sanada F, Kim J, Czarna A, Chan NY, Signore S, Ogórek B, Isobe K, Wybieralska E, Borghetti G, Pesapane A, Sorrentino A, Mangano E, Cappetta D, Mangiaracina C, Ricciardi M, Cimini M, Ifedigbo E, Perrella MA, Goichberg P, Choi AM, Kajstura J, Hosoda T, Rota M, Anversa P, Leri A.

Circ Res. 2014 Jan 3;114(1):41-55. doi: 10.1161/CIRCRESAHA.114.302500. Erratum in: Circ Res. 2015 Jul 31;117(4):e54.

15.

Mechanisms of remodelling: a question of life (stem cell production) and death (myocyte apoptosis).

Ferrari R, Ceconi C, Campo G, Cangiano E, Cavazza C, Secchiero P, Tavazzi L.

Circ J. 2009 Nov;73(11):1973-82. Review.

16.

Apoptosis in heart failure and the senescent heart.

Bernecker OY, Huq F, Heist EK, Podesser BK, Hajjar RJ.

Cardiovasc Toxicol. 2003;3(3):183-90. Review.

PMID:
14555785
17.

Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts.

Wang L, Deng J, Tian W, Xiang B, Yang T, Li G, Wang J, Gruwel M, Kashour T, Rendell J, Glogowski M, Tomanek B, Freed D, Deslauriers R, Arora RC, Tian G.

Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H1020-31. doi: 10.1152/ajpheart.01082.2008.

18.

Stem cells for heart failure in the aging heart.

Ballard VL.

Heart Fail Rev. 2010 Sep;15(5):447-56. doi: 10.1007/s10741-010-9160-z. Review.

PMID:
20225094
19.

Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.

De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, Rota M, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P.

Circulation. 2010 Jan 19;121(2):276-92. doi: 10.1161/CIRCULATIONAHA.109.895771.

20.

Cardiac primitive cells become committed to a cardiac fate in adult human heart with chronic ischemic disease but fail to acquire mature phenotype: genetic and phenotypic study.

Nurzynska D, Di Meglio F, Romano V, Miraglia R, Sacco AM, Latino F, Bancone C, Della Corte A, Maiello C, Amarelli C, Montagnani S, Castaldo C.

Basic Res Cardiol. 2013 Jan;108(1):320. doi: 10.1007/s00395-012-0320-2.

PMID:
23224139
Items per page

Supplemental Content

Support Center